IP Library Granted Patent US 9,504,827
Granted Patent B2
US 9,504,827 · App. 14/721,300 · Granted Nov 29, 2016

Systems, devices and methods for the treatment of neurological disorders and conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,504,827
App. No.
14/721,300
Granted
Nov 29, 2016
Kind
B2
Abstract

The present disclosure relates to methods, devices, and systems used for the treatment of and/or promoting recovery from various neurological disorders and conditions, including epilepsy and other seizure disorders and movement and other related disorders; for promoting recovery from acute or chronic brain injury (e.g. stroke, hypoxia/ischemia, head trauma, subarachnoid hemorrhage, and other forms of brain injury, for awakening and/or promoting the recovery of patients in various levels of coma, altered mental status or vegetative state); or for promoting recovery from chronic daily headache and migraine and related disorders via external (cutaneous) stimulation of the sensory branches of the trigeminal nerve in the face and forehead. More specifically, devices and electrode assemblies configured for stimulation of the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and infratrochlear nerves are disclosed.

Claims (10)

1. A system for trigeminal nerve stimulation for treatment of a neurological disorder or condition, the system comprising:

a pulse generator; and

a cutaneous electrode assembly in electrical communication with the pulse generator, the assembly comprising:

a first electrode comprising at least one contact configured for cutaneous placement over an ophthalmic nerve on one side of a patient's forehead;

a second electrode comprising at least one contact configured for cutaneous placement over an ophthalmic nerve on an opposing side of the patient's forehead; and

an insulating region surrounding each of the first and second electrodes.

2. A method for treating a neurological disorder or condition by trigeminal nerve stimulation, comprising:

aligning a cutaneous electrode assembly with the nasal midline of a patient, wherein the cutaneous electrode assembly includes a first contact separated from a second contact by an expected separation between the ophthalmic nerves on the patient's forehead;

applying the aligned cutaneous electrode assembly on the patient's forehead such that the first contact overlays a first one of the ophthalmic nerves and the second contact overlays a remaining second one of the ophthalmic nerves on the patient's forehead; and

driving electrical signals through the applied cutaneous electrode assembly to treat the neurological disorder or condition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2017
From: DEGIORGIO, CHRISTOPHER M.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 043591/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2016
From: MILLER, PATRICK
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 038645/0410 →